TCMBANKIN038735 |
nardostachin |
3-methylbutanoic acid [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-4-[(3-methyl-1-oxobutoxy)methyl]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] ester; AC1L5267; 114687-82-0; DTXSID80150830; 3-methylbutyric acid [(1S,4aS,6S,7R,7aS)-6-hydroxy-4-(isovaleryloxymethyl)-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] ester; [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-(3-methylbutanoyloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate; Butanoic acid, 3-methyl-, (1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-1-(3-methyl-1-oxobutoxy)cyclopenta(c)pyran-4-yl)methyl ester, (1S-(1alpha,4aalpha,6alpha,7alpha,7aalpha))-; [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-4-(3-methylbutanoyloxymethyl)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] 3-methylbutanoate; nardostachin |
C20H32O6 |
368 |
[C@@]12([H])[C@@]([H])([C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H])[C@]([H])(OC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])OC([H])=C2C([H])([H])OC(C([H])([H])C([H])(C([H])([H])[H])C([
H])([H])[H])=O |